HemaSphere
(Jun 2022)
PB2178: OUTCOMES OF REDUCED DOSE TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION FOR HODGKIN AND NON-HODGKIN LYMPHOMA: A MONOCENTRIC EXPERIENCE
S. Di Folca,
V. Marafioti,
S. barbato,
S. Avilia,
F. Grimaldi,
A. Severino,
M. Picardi,
L. Luciano,
G. Battipaglia,
F. Pane
Affiliations
S. Di Folca
1 Ematologia, AOU Federico II, napoli, Italy
V. Marafioti
1 Ematologia, AOU Federico II, napoli, Italy
S. barbato
1 Ematologia, AOU Federico II, napoli, Italy
S. Avilia
1 Ematologia, AOU Federico II, napoli, Italy
F. Grimaldi
1 Ematologia, AOU Federico II, napoli, Italy
A. Severino
1 Ematologia, AOU Federico II, napoli, Italy
M. Picardi
1 Ematologia, AOU Federico II, napoli, Italy
L. Luciano
1 Ematologia, AOU Federico II, napoli, Italy
G. Battipaglia
1 Ematologia, AOU Federico II, napoli, Italy
F. Pane
1 Ematologia, AOU Federico II, napoli, Italy
DOI
https://doi.org/10.1097/01.HS9.0000851540.26904.c2
Journal volume & issue
Vol. 6
pp.
2048
– 2049
WeChat QR code
Close